Data as of Q4 2025 (Dec 31, 2025)

ALETHEA CAPITAL MANAGEMENT, LLC

•CIK: 1549408•Filing: Q4 2025

ALETHEA CAPITAL MANAGEMENT, LLC manages $206M across a concentrated portfolio of 13 positions. The fund exhibits a significant overweight to AXSM, representing $122.1M of its total assets. Notable allocations include substantial positions in RNAM ($32.2M) and BIL ($21.6M). This structure suggests a tactical focus, with the top five holdings accounting for over 88% of the reported AUM.

Total AUM
$205.9M
QoQ Performance
+32.5%
Positions
13
Top 10 Concentration
99.9%
Latest Filing
Q4 2025

Top Holdings Allocation

AXSM
RNAGBP
BIL
KURA
AXSM59.3%
RNAGBP15.6%
BIL10.5%
KURA7.2%
SPY4.6%
TLT1.0%
TEM0.9%
CDTX0.5%

📈 Biggest Buys

SPY
SPDR S&P 500 ETF TR
NEW
4.6% of portfolio
TEM
TEMPUS AI INC
NEW
0.9% of portfolio
KURA
KURA ONCOLOGY INC
+2.4%
7.2% of portfolio

📉 Biggest Sells

BIL
SPDR SERIES TRUST
-24.2%
10.5% of portfolio
AXSM
AXSOME THERAPEUTICS INC
-0.3%
59.3% of portfolio
CDTX
CIDARA THERAPEUTICS INC
-22.3%
0.5% of portfolio
HEDJ
WISDOMTREE TR
-6.2%
0.2% of portfolio
RSPU
INVESCO EXCHANGE TRADED FD T
-0.9%
0.1% of portfolio

Sector Breakdown

Other95.4%
ETF4.6%

🚪 Exited Positionssold since Q3 2025

JNJ
JOHNSON & JOHNSON
SOLD
$616.2K
VEN
VENTAS INC
SOLD
$562.7K
UNH
UNITEDHEALTH GROUP INC
SOLD
$561.8K
SJM
SMUCKER J M CO
SOLD
$561.5K
CNP
CENTERPOINT ENERGY INC
SOLD
$536.2K
+17 more exited positions

Changes from Q3 2025

NEW2 new positions
↑1 increased
↓5 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

📌 Top Holdings

AXSM59.3%
AXSOME THERAPEUTICS INC
$122.1M
RNAGBP15.6%
AVIDITY BIOSCIENCES INC
$32.2M
BIL10.5%
SPDR SERIES TRUST
$21.6M
KURA7.2%
KURA ONCOLOGY INC
$14.8M
SPY4.6%
SPDR S&P 500 ETF TR
$9.5M

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.